Of relevance, the density of CD8+ T cell infiltrates in the invasive margins of melanoma lesions has been associated with expression of the PD-1/PD-L1 immune inhibitory axis and with clinical responses to anti-PD-1 immunotherapy [23]. This evidence concerns the gene CD8A and melanoma.